University Hospital Foundation Jimenez Diaz

Madrid 28040

1 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumor, Bladder Cancer, Breast Cancer, Cerebrospinal Fluid Leak, Dedifferentiated Liposarcoma, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Lymphoma, T-Cell, Mesothelioma, Malignant, Metastatic Castration-resistant Prostate Cancer, Metastatic Small Cell Lung Cancer, Ovarian Clear Cell Carcinoma

Studies at this site

• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
• A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling
• Study to Assess AFM24 in Advanced Solid Cancers — Stopped early
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer — Completed
• Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery — Completed